GMP-based CD133(+) cells isolation maintains progenitor angiogenic properties and enhances standardization in cardiovascular cell therapy.
J Cell Mol Med
; 14(6B): 1619-34, 2010 Jun.
Article
in En
| MEDLINE
| ID: mdl-19627397
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Peptides
/
Stem Cells
/
Glycoproteins
/
Cardiovascular Diseases
/
Antigens, CD
/
Cell Separation
/
Neovascularization, Physiologic
/
Stem Cell Transplantation
Type of study:
Clinical_trials
/
Guideline
/
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
J Cell Mol Med
Journal subject:
BIOLOGIA MOLECULAR
Year:
2010
Document type:
Article
Affiliation country:
Italy
Country of publication:
United kingdom